NEW YORK (GenomeWeb) – CombiMatrix reported after the close of the market on Wednesday that its second quarter revenues rose 22 percent from Q2 2015, thanks in large part to a 7 percent increase in total test volume for the period.

For the three months ended June 30, the firm reported total revenues of $3.1 million, up from $2.5 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.